Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Invesco Ltd.NYSE: IVZ
Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026
Other income / expenses growth accelerates
Q2 FY2026 other income / expenses of $91.2M rose 51.5% year over year, ahead of the +38.5% change in trailing-twelve-month other income / expenses.
Context
- Other income / expenses amounted to 5.0% of revenue in FY2025, up 2.1 pp from a year earlier.
- Other income / expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +51.5% holds above the trailing-twelve-month pace of +38.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 316.3M USD
- Year-over-year change
- +82.6%
- 4-year CAGR
- -18.4%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 316.3M | +82.6% |
| FY2024 | 2024-12-31 | 173.2M | -12.0% |
| FY2023 | 2023-12-31 | 196.9M | +381.3% |
| FY2022 | 2022-12-31 | (70M) | -109.8% |
| FY2021 | 2021-12-31 | 712.3M | — |
Other Income / Expenses vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 other income / expenses of $246.7M is the 4th highest of the 11 companies compared; the peer median is $26.65M.
- Its year-over-year change of +38.5% is the 4th highest of 9, against a peer median of +20.4%.
- Other income / expenses amounts to 3.6% of revenue for IVZ, versus a peer median of 4.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $738.4M | +41.1% | — | 9.7% | |
| LTM Jun 2026 | $617.2M | +421.7% | +45.5% | 6.6% | |
| LTM Sep 2026 | $570.3M | +48.9% | -24.2% | 22.0% | |
| LTM Jun 2026 | $246.7M | +38.5% | — | 3.6% | |
| LTM Sep 2026 | $166.39M | -40.4% | +29.4% | 6.6% | |
| LTM Sep 2026 | $48.87M | -36.9% | — | 3.9% | |
| LTM Mar 2026 | $4.44M | +38.4% | — | 4.5% | |
| LTM Mar 2026 | $344K | -47.6% | — | 1.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | -$41.1M | — | — | 0.3% | |
| LTM Jun 2026 | -$328M | +2.4% | — | 1.7% | |
| Peer median (excluding IVZ) | $26.65M | +20.4% | +29.4% | 4.2% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.89B | 6.05B | 5.72B | 6.07B | 6.38B |
| Cost of Revenue | 4.06B | 3.61B | 3.71B | 4.04B | 3.62B |
| Gross Profit | 2.83B | 2.44B | 2.01B | 2.03B | 2.75B |
| Gross Margin | 41.1% | 40.3% | 35.1% | 33.4% | 43.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 522.7M | 588.2M | 649.7M | 676M | 660.5M |
| Operating Expenses | 1.05B | 1.12B | 2.44B | 1.2B | 3.45B |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| EBITDA | 2.8B | 1.53B | 15.4M | 1.24B | (390.8M) |
| EBITDA Margin | 40.6% | 25.3% | 0.3% | 20.5% | -6.1% |
| Operating Income | 1.79B | 1.32B | (434.8M) | 832.1M | (695.7M) |
| Operating Margin | 25.9% | 21.8% | -7.6% | 13.7% | -10.9% |
| Interest Income | 25.2M | 24.4M | 47.8M | 58.9M | 53.9M |
| Interest Expense | 94.7M | 85.2M | 70.5M | 58M | 82.5M |
| Other Income / Expenses | 712.3M | (70M) | 196.9M | 173.2M | 316.3M |
| Income Before Tax | 2.5B | 1.25B | (237.9M) | 1.01B | (379.4M) |
| Pre-Tax Margin | 36.3% | 20.6% | -4.2% | 16.6% | -5.9% |
| Income Tax Expense | 531.1M | 322.2M | (69.7M) | 252.9M | (204.6M) |
| Net Income | 1.63B | 920.7M | (96.9M) | 774.8M | (281.7M) |
| Net Margin | 23.6% | 15.2% | -1.7% | 12.8% | -4.4% |
| EPS (Basic) | 3.01 | 1.50 | (0.73) | 1.18 | (1.61) |
| EPS (Diluted) | 2.99 | 1.49 | (0.73) | 1.18 | (1.60) |
| Weighted Avg Shares | 462.8M | 457.5M | 454.8M | 457M | 451.2M |
| Weighted Avg Shares (Diluted) | 465.4M | 459.5M | 456.2M | 457.7M | 453.8M |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.